Clinical Trial Results:
A randomized, controlled, open-label, multi-center, parallel-group study to compare the efficacy and safety of RO0503821 with that of darbepoetin alfa administered intravenously at extended dosing intervals for the maintenance treatment of anemia in patients with chronic kidney disease who are on hemodialysis
Summary
|
|
EudraCT number |
2005-004510-33 |
Trial protocol |
DE GB AT FI BE PT NL DK IT ES |
Global completion date |
27 Nov 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
05 Feb 2017
|
First version publication date |
05 Feb 2017
|
Other versions |
|
Summary report(s) |
CTg Receipt - BH17847 Final |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.